13D/13G Filings - Frazier Life Sciences X L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-12-17
10:28 am
Purchase
2024-12-13 13D NewAmsterdam Pharma Company N.V.
NAMS
Frazier Life Sciences X L.P. 16,416,751
15.300%
3,784,713increase
(+29.96%)
Filing
History
2024-02-21
11:11 am
Unchanged
2024-02-16 13D NewAmsterdam Pharma Company N.V.
NAMS
Frazier Life Sciences X L.P. 12,632,038
14.200%
0
(Unchanged)
Filing
History
2023-08-15
4:02 pm
Purchase
2023-08-11 13D NewAmsterdam Pharma Company N.V.
NAMS
Frazier Life Sciences X L.P. 12,632,038
15.300%
1,485,807increase
(+13.33%)
Filing
History
2023-06-09
3:47 pm
Purchase
2023-06-07 13D NewAmsterdam Pharma Company N.V.
NAMS
Frazier Life Sciences X L.P. 11,146,231
13.500%
11,146,231increase
(New Position)
Filing
History